Breast surgery after neoadjuvant chemotherapy in patients with lobular carcinoma: surgical and oncologic outcome Por [email protected] Breast surgery after neoadjuvant chemotherapy in patients with lobular carcinoma: surgical and oncologic outcome Read More »
Adjuvant Chemotherapy in Premenopausal Patients With Hormone-Positive Breast Cancer With a Recurrence Score of 16-25: A Retrospective Analysis Using the National Cancer Database Por [email protected] Adjuvant Chemotherapy in Premenopausal Patients With Hormone-Positive Breast Cancer With a Recurrence Score of 16-25: A Retrospective Analysis Using the National Cancer Database Read More »
Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases Por [email protected] Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases Read More »
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative Metastatic Breast Cance Por [email protected] PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative Metastatic Breast Cance Read More »
Oncologic safety of breast conserving surgery after neoadjuvant chemotherapy in patients with multiple ipsilateral breast cancer: A retrospective multi-institutional cohort study Por [email protected] Oncologic safety of breast conserving surgery after neoadjuvant chemotherapy in patients with multiple ipsilateral breast cancer: A retrospective multi-institutional cohort study Read More »
Ribociclib plus Endocrine Therapyin Early Breast Cancer Por [email protected] Ribociclib plus Endocrine Therapyin Early Breast Cancer Read More »
Immediate and delayed risk of breast cancer associated with classiclobular carcinoma in situ and its variants Por [email protected] Immediate and delayed risk of breast cancer associated with classiclobular carcinoma in situ and its variants Read More »
Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations Por Adson Machado Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations Read More »
Endocrine and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer—Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update Por Adson Machado Endocrine and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer—Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update Read More »
MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations Por Adson Machado MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations Read More »
Abemaciclibe combinado com terapia endócrina no tratamento adjuvante de tumores iniciais de alto risco, RH+, HER2-, axila negativa (monarchE) Por [email protected] Abemaciclibe combinado com terapia endócrina no tratamento adjuvante de tumores iniciais de alto risco, RH+, HER2-, axila negativa (monarchE) Read More »
Incidência de Câncer de Mama invasivo em mulheres tratadas com Implantes de Testosterona Por Adson Machado Incidência de Câncer de Mama invasivo em mulheres tratadas com Implantes de Testosterona Read More »
